HopeStage
Back to all studies
CompletedNCT00376220

Riluzole for bipolar depression

About this titleRead the official source — NCT00376220

Researchers compared Riluzole and placebo to find out how the approaches affected depression symptoms in people with bipolarity during a depressive episode.

Medication studyAges 18–75United States
The study in practice

Understand this study

What did researchers investigate?

Researchers compared Riluzole and placebo to find out how the approaches affected depression symptoms in people with bipolarity during a depressive episode.

Who was this study for?

This study was for people with bipolarity. Listed age limits: 18 years to 75 years. Other eligibility criteria applied.

Listed locations
BaltimoreSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateMay 2004
Recruitment status
Completed
Enrollment listed in the registry
94
Sponsor
Johns Hopkins University
Sponsor type
University
Study type
Drug
Intervention type
Drug, Other
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 75 Years
Official registry ID
NCT00376220
Official title
Show the full official title

A Double-Blind Placebo Controlled Trial of Riluzole in Bipolar Depression

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Baltimore

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

What did researchers investigate?

Researchers compared Riluzole and placebo to find out how the approaches affected depression symptoms in people with bipolarity during a depressive episode.

Who is behind this study?

The study sponsor is Johns Hopkins University, a university.

Did this study involve medication?

Yes. The study involved medication, including Riluzole.

Who was this study for?

This study was for people with bipolarity. Listed age limits: 18 years to 75 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies